Age at Weaning and Infant Growth: Primary Analysis and Systematic Review

Brennan Vail1, Philippa Prentice2, David B Dunger2

  • 1Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; School of Medicine, University of California San Francisco, San Francisco, CA.

Insights

Early weaning (3-6 months) does not impact infant growth in high-income countries. Faster infant weight gain before weaning may influence the timing of introduction of solid foods, suggesting reverse causality.

Area of Science:

  • Pediatrics
  • Human Growth and Development
  • Nutritional Science

Background:

  • Early infant feeding practices, including weaning, are crucial for optimal child development.
  • Understanding the relationship between weaning age and infant growth is essential for public health guidelines.

Purpose of the Study:

  • To investigate the association between early age at weaning (3-6 months) and infant growth trajectories.
  • To explore potential reverse causality in the observed associations.

Main Methods:

  • Prospective birth cohort study of 571 mothers in Cambridge, UK.
  • Infant anthropometric measurements (weight, length) at birth, 3, and 12 months.
  • Linear regression models adjusted for maternal and demographic factors, and milk feeding type.

Main Results:

  • Weaning between 3-7 months showed an inverse association with infant weight and length at 12 months, which attenuated after controlling for early growth and milk feeding.
  • Rapid infant weight gain between 0-3 months predicted earlier weaning.
  • A systematic review of existing literature indicated mixed findings, with a notable proportion of observational studies suggesting reverse causality.

Conclusions:

  • Weaning between 3-6 months appears to have a neutral effect on infant growth in high-income settings.
  • Observed inverse associations between early weaning and infant growth are likely attributable to reverse causality, where infant growth influences weaning timing.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
859
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
2.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
352
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
41
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
811
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
496